| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.00B | -3.7% | +9.7% |
| Cost of Revenue | $559.3M | -5.6% | +3.8% |
| R&D Expense | $115.9M | +2.3% | +3.9% |
| SG&A Expense | $811.4M | -0.4% | +14.3% |
| Operating Income | $351.3M | +17.1% | +25.7% |
| Pre-tax Income | $279.2M | +24.3% | +21.2% |
| Income Tax | $48.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.29B | +132.1% | +127.2% |
| Accounts Receivable | $1.60B | -0.8% | +7.9% |
| Inventory | $2.48B | +1.2% | +4.9% |
| Current Assets | $5.83B | +15.5% | +20.0% |
| Total Assets | $23.49B | +2.7% | +8.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.18B | — | — |
| Capital Expenditures | $149.7M | — | — |
| Investing Cash Flow | -$1.65B | — | — |
| Financing Cash Flow | $1.22B | — | — |
| Free Cash Flow | $1.03B | — | — |
| -32.6% |
| +354.0% |
| Net Income | $230.9M | +51.1% | -7.3% |
| EPS (Basic) | $1.17 | +51.9% | -4.9% |
| EPS (Diluted) | $1.16 | +50.6% | -5.7% |
| $2.40B |
| -11.0% |
| -32.7% |
| Long-term Debt | $7.51B | +11.3% | +58.6% |
| Total Liabilities | $10.72B | +3.8% | +14.8% |
| Stockholders' Equity | $12.76B | +1.8% | +3.1% |